Why is Choksi Laborator falling/rising?

As of 15-Sep, Choksi Laboratories Ltd is experiencing a decline in its stock price, currently at Rs 194.70, which reflects a decrease of Rs 4.8 or 2.41%. The stock has been underperforming, having lost 13.47% over the last four days, and it opened today with a gain of 4.56%, reaching an intraday high of Rs 208.6 before dropping to a low of Rs 191.35. Despite a strong year-to-date return of 159.36%, the stock has faced challenges recently, including a negative performance of -11.96% over the past week and -8.87% over the past month. The stock's valuation appears attractive with a ROCE of 9.5 and a PEG ratio of 3.2, but it also has a high Debt to EBITDA ratio of 3.69, indicating potential long-term fundamental weaknesses.
In the broader market context, Choksi Laboratories' recent performance contrasts sharply with the Sensex, which has gained 1.24% over the past week and 1.47% over the past month. This underperformance may be attributed to the stock's weak long-term growth prospects, as evidenced by a modest annual sales growth rate of 11.11% over the last five years. While institutional investors have increased their stake by 2.37%, suggesting some confidence in the company's fundamentals, the overall market sentiment appears to be cautious, particularly given the stock's recent consecutive declines and the flat results reported in June.